Hormone replacement therapy in women with breast cancer

Anticancer Research

Volumn 18, Issue 3 C, 1998, Pages 2253-2255

  Braendle, Wilhelm ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Abt F Gynakol Endokrinol R   (Germany)

Author keywords

Breast cancer; ERT; HRT

Indexed keywords

ESTROGEN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER HORMONE THERAPY; EARLY DIAGNOSIS; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; PROGESTINS;

EID: 0031863811     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Colditz GA, Hankinson SE, Hunter DJ, Willet, WC, Manson JE, Stamlrer MJ, Hennekens C, Rosner B, Speizer FE: The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. N Engl J Med 332: 1589-1593, 1995.
2. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL: A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer. JAMA 265: 1985-1990, 1991.
3. Baron J, Bogdan G, Clapp RW, Longnecker MP, Mittendorr R, Newcomb PA, Storer BE, Willett WC: Long-term Hormone Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women. Am J Epidemiol 142: 788-795, 1995.
4. Ewertz M: Hormone Therapy in the Menopause and Breast Cancer Risk - a Review. Maturitas 23: 241 -246, 1996.
5. Paganini-Hill A: Estrogen Replacement Therapy in the Elderly. Zentralbl. Gynäkol 118: 255-261, 1996.
6. Kuhl H, Runnebaum B, Schneider HPG: Langfristige Horrnonsubstitution und Mammakarzinomrisiko: Aktuellc Bestandsaufnahme. Zentralbl. F. Gyn 117: 549-553, 1995.
7. Söderqvist G, Isaksson E, von Schoultz B, Carlstrm K, Tani E, Skoog L: Proliferation of Breast Epithelial Cells in Healthy Women during the Menstrual Cycle. Am J Obst Gyn 176: 123-128, 1997.
8. Bonnier P, Romain S, Giacalone PL, Laffargue F, Martin PM, Piana L: Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy. Obst Gyn 85: 11 - 17, 1995.
9. Harding, C, Knox WF, Faragher EB, Baildam A, Bundred NJ: Hormone Replacement Therapy and Tumour Grade in Breast Cancer: Prospective Study in Screening Unit. BMJ 312: 1646-1647, 1996.
10. Helzlsouer K and Couzi R: Hormones and Breast Cancer. Cancer 76: 2059-2063, 1995.
11. Maass H.: Hormonsubstitution in der Postmenopause nach Mammakarzinom. Dtsch.Arzteblatt 87: 874, 1990.
12. Dodapkar MV, Ingle JN, Ahmann DL: Estrogen Replacement Therapy Withdrawal and Regression of Metastatic Breast Cancer. Cancer 75: 43-46, 1995.
13. th International Congress on the Menopause. November 1996 F 170
14. Wile AG, Opfell RW, Margileth DA: Hormone Replacement Therapy in Previously Treated Breast Cancer Patients. Am J Surg 165: 372-375, 1993.
15. Eden J: Hormone Replacement Therapy afcer Breast Cancer. In: Progress in Reproductive Medicine (Ash R and Studd J), New York, Parthenon Corp, 1995, pp 177-183.
16. DiSaia PJ, Grosen EA, Odicino F, Cowan B, Pecorelli S, Wile AG, Creasman WT: Replacement Therapy for Breast Cancer Survivors. Cancer 76: 2075-2078, 1995.
17. Wren BG.: Hormonal Replacement Therapy and Breast Cancer. European Menopause J 2: 13-19, 1995.
18. Eden JA, Bush T, Nand S, Wren BG: A Case-Control Study of Combined Continuous Estrogen-Progestin Replacement Therapy among Women with a Personal History of Breast Cancer. Menopause 2: 67-72, 1995.
19. DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H: Hormone Replacement Therapy in Breast Cancer Survivors: A Cohort Study. Am J Obst and Gyn 174: 1494-1498, 1996.
20. Sands R, Boshoff C, Jones A, Studd J: Hormone Replacement Therapy after a Diagnosis of Breast Cancer. Menopause 2: 73-80, 1995.
21. Roy JA, Sawka CA, Pritchard KI: Hormone Replacement Therapy in Women with Breast Cancer: Do the Risk Outweigh the Benefits? J Clin Oncology 14: 997-1006, 1996.
22. O'Brien M, Montes A, Powles TJ: Hormone Replacement Therapy as Treatment of Breast Cancer - a Phase II Study of Org OD 14 (Tibolone). BrJCancer 73: 1086-88, 1996.
23. Kaufmann M, von Minckwitz V: Das primare Mammakarzinom. Deutsches Arzteblatt 93: 598-600, 1996.
24. Kaufmann M: Das primare Mammakarzinom - Therapievorschlage. Der Frauenarzt 1: 68-71, 1996.